Advertisment
|
|
|
news roundup
Cenduit’s division will provide hands-on experience for managing and enhancing Interactive Response Technology (IRT) systems.
The 200 investigators provide care to approximately 600,000 kidney disease patients.
advertisment
CBI's Clinical Technologies Conference, taking place this March in Philadelphia. CBI's Clinical Technology Congress offers the opportunity for clinical executives to gain insight into utilizing technology to enable efficient, cost-effective trials while maintaining data control. With a focus on process and data stewardship, attendees walk away with best practices to streamline trial execution through enabling technology at the sponsor/CRO, research site and patient level
click here
|
The changes will enable study sites to access central lab data in real time, improve inventory management and order tracking, facilitate patient management and safety and more.
|
|
Regulatory
An investigation published by The BMJ has raised concerns from the U.S. and European regulators about the validity of a pivotal trial.
The French national drug safety agency released the timeline of events for the Phase I clinical trial of BIA 10-2474.
With clinical research expert Robert Califf slated to take the helm of the agency, initiatives to streamline trials will be a prime area of focus.
The new approach adopted by the EMA's Pharmacovigilance Risk Assessment Committee builds on existing activities in the member states and the agency.
|
|
|
advertisment
|
|
Subscribe
|
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »
|
|
|
advertisment
|
|
|
Articles
A survey conducted in Germany has shown that in the pharmaceutical environment, the number of SOPs and related documents is increasing.
|
|
|
Blog Posts
Inn the world of clinical research, the data privacy threat is one that was raised long ago and mitigated by regulatory agencies.
|
|
|
|
Read the digital edition of Applied Clinical Trials Click here to sign up or renew your subscription
|
|
|
|
|